Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
8,321,792
-
Shares change
-
+667,731
-
Total reported value, excl. options
-
$638,198,251
-
Value change
-
+$51,685,578
-
Put/Call ratio
-
293%
-
Number of buys
-
50
-
Number of sells
-
-31
-
Price
-
$76.69
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2014
94 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q1 2014.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,321,792 shares
.
Largest 10 shareholders include MORGAN STANLEY (2,244,111 shares), WELLS FARGO & COMPANY/MN (1,617,445 shares), GOLDMAN SACHS GROUP INC (767,083 shares), BANK OF AMERICA CORP /DE/ (604,254 shares), UBS AG (578,282 shares), RAYMOND JAMES & ASSOCIATES (304,071 shares), FIRST TRUST ADVISORS LP (285,143 shares), LPL Financial LLC (247,104 shares), ROYAL BANK OF CANADA (146,383 shares), and Valentine Capital Asset Management, Inc. (86,195 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.